Inge Marie Svane

Inge Marie Svane

Clinical Professor


  1. 2020
  2. Published

    Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

    Araujo B de Lima, V., Borch, A., Hansen, M., Draghi, A., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, Ulrik Niels & Svane, Inge Marie, Apr 2020, In : Cytotherapy. 22, 4, p. 204-213 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer

    Friese, C., Harbst, K., Borch, T. H., Westergaard, M. C. W., Pedersen, M., Kverneland, A., Jönsson, G., dqp123, dqp123, Svane, Inge Marie & Met, Özcan, 2020, In : Scientific Reports. 10, 1, 12 p., 3914.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors

    Romanski, N. A., Holmstrøm, Rikke Bødker, Ellebaek, E. & Svane, Inge Marie, 2020, In : European Journal of Cancer. 130, p. 211-218

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

    Crowther, M. D., Dolton, G., Legut, M., Caillaud, M. E., Lloyd, A., Attaf, M., Galloway, S. A. E., Rius, C., Farrell, C. P., Szomolay, B., Ager, A., Parker, A. L., Fuller, A., dqp123, dqp123, McCluskey, J., Rossjohn, J., Svane, Inge Marie, Phillips, J. D. & Sewell, A. K., 2020, In : Nature Immunology. 21, 2, p. 178-185 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade

    Jensen, C., Sinkeviciute, D., Madsen, D. H., Onnerfjord, P., Hansen, M., Schmidt, H., Karsdal, M. A., Svane, Inge Marie & Willumsen, N., 2020, In : Cancers. 12, 10, p. 1-15 2786.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes

    Nielsen, M., Krarup-Hansen, Anders, Hovgaard, D., Petersen, Michael Mørk, Loya, Anand Chainsukh, Westergaard, M. C. W., Svane, Inge Marie & Junker, N., 2020, In : Cancer Immunology, Immunotherapy. 69, p. 2179-2191

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

    Jørgensen, N. G., Klausen, U., Grauslund, Jacob Handlos, Helleberg, C., Aagaard, T. G., Do, T. H., Ahmad, S. M., Olsen, L. R., Klausen, T. W., Breinholt, M. F., Hansen, M., Martinenaite, E., Met, Özcan, Svane, Inge Marie, Knudsen, L. M. & Andersen, Mads Hald, 2020, In : Frontiers in Immunology. 11, 11 p., 595035.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8+ T cells in non-melanoma cancers compared to melanoma

    Gokuldass, A., Draghi, A., Papp, K., Borch, T. H., Nielsen, M., Westergaard, M. C. W., Andersen, R., Schina, Aimilia, Bol, K. F., Chamberlain, C. A., Presti, M., Met, Özcan, Harbst, K., Lauss, M., Soraggi, S., Csabai, I., Szállási, Z., Jönsson, G., Svane, Inge Marie & dqp123, dqp123, 2020, In : Cancers. 12, 11, p. 1-15 15 p., 3344.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road

    Crowther, M. D., Svane, Inge Marie & Met, Özcan, 2020, In : Cells. 9, 7, 18 p., 1588.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

    Weis-Banke, S. E., Hübbe, M. L., Holmström, M. O., Jørgensen, M. A., Bendtsen, S. K., Martinenaite, E., Carretta, M., Svane, Inge Marie, Ødum, Niels, Pedersen, A. W., Met, Özcan, Madsen, D. H. & Andersen, Mads Hald, 2020, In : OncoImmunology. 9, 1, 16 p., 1771142.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 4054758